ALDX Announces Positive Primary Vitreoretinal Lymphoma Pre-NDA Meeting with the FDA.
Plans to submit an NDA as soon as EOY. Intends to Request Priority Review.$Aldeyra Therapeutics(ALDX)$
| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
ALDX Announces Positive Primary Vitreoretinal Lymphoma Pre-NDA Meeting with the FDA.
Plans to submit an NDA as soon as EOY. Intends to Request Priority Review.$Aldeyra Therapeutics(ALDX)$